Traditional Chinese medicine Huanglian in the treatment of diabetes mellitus: a registration study
- Conditions
- diabetes
- Registration Number
- ITMCTR2200006187
- Lead Sponsor
- Guang'anmen Hospital, Chinese Academy of traditional Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- Not specified
1)The age is 18 to 70 years old (including boundary value), and there is no limit on gender;
2)Meet the diagnostic criteria of diabetes in modern medicine;
3)lt is planned to start taking traditional Chinese medicine prescriptions containing Coptidis Rhizoma to treat the disease;
4) Informed consent has been signed.
1) Those who currently have more serious underlying diseases;
2) Patients who are taking other drugs that have significant effects on gastrointestinal function as judged by the doctor at the same time;
3) Those who are allergic to the known ingredients of the research drug and have allergic constitution;
4) The patient is complicated with other serious diseases or mental disorders;
5) Pregnant and lactating women.
Study & Design
- Study Type
- Observational study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Twelve lead ECG;Common Gastrointestinal Side Effects Scale;kidney function;Glu;liver function;HbAlc;
- Secondary Outcome Measures
Name Time Method